The most common GLP-1 drugs you may have heard of include: These medications help people lose significant weight and reduce the risk of serious heart problems
According to the National Institute on Drug Abuse (NIDA), individuals dependent on these medications may experience cravings, mood swings, and physical withdrawal symptoms such as nausea, sweating, and muscle pain when not taking the drug
However, talking to your insurance provider is the only way to know whether youre covered and, if so, how much of a copay or coinsurance youll be expected to pay out of pocket
Can Retatrutide be used as a weight loss product
Amycretin is another option being developed by Novo Nordisk that targets amylin and GLP-1 receptors in one medication
Identified by CAS Number 2381089-83-2, Retatrutide is widely referenced in metabolic and obesity research literature as the first characterized triple agonist targeting the GIP receptor, GLP-1 receptor, and glucagon receptor (GCGR) simultaneously within a single molecular scaffold